Microglia-derived cytokines/chemokines are involved in the enhancement of LPS-induced loss of nigrostriatal dopaminergic neurons in DJ-1 knockout mice

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Chien, Chia Hung ^a,c   Lee, Ming Jen ^b   Liou, Houng Chi ^c   Liou, Horng Huei ^b,c   Fu, Wen Mei ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; DOPAMINE; GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; CHEMOKINE; CYTOKINE; ONCOPROTEIN; PARK7 PROTEIN, MOUSE; PEROXIREDOXIN; PROTEIN DEGLYCASE DJ-1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DJ 1MOUSE; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; GLIA CELL; INFLAMMATION; KNOCKOUT MOUSE; MALE; MICROGLIA; MOLECULAR MECHANICS; MOUSE; NERVE CELL NECROSIS; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SENSITIZATION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; ANIMAL; CELL LINE; CORPUS STRIATUM; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; NERVE CELL; PHYSIOLOGY;

ANIMALS; CELL LINE; CHEMOKINES; CORPUS STRIATUM; CYTOKINES; DOPAMINE; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; MICROGLIA; NEURONS; ONCOGENE PROTEINS; PEROXIREDOXINS; PROTEIN DEGLYCASE DJ-1; SUBSTANTIA NIGRA;

EID: 84978105225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151569     Document Type: Article

References (53)

1. Chung KK, Dawson VL, Dawson TM. New insights into Parkinson's disease. Journal of neurology. 2003; 250 Suppl 3:III15-24. doi: 10.1007/s00415-003-1304-9 PMID: 14579120.
2. Thomas KJ, Cookson MR. The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics. The international journal of biochemistry & cell biology. 2009; 41(10):2025-35. doi: 10.1016/j.biocel.2009.02.018 PMID: 19703660; PubMed Central PMCID: PMC2732569.
3. Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, et al. DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2003; 24(3):159-60. doi: 10.1007/s10072-003-0108-0 PMID: 14598065.
4. Pham TT, Giesert F, Rothig A, Floss T, Kallnik M, Weindl K, et al. DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments. Genes, brain, and behavior. 2010; 9(3):305-17. doi: 10.1111/j.1601-183X.2009.00559.x PMID: 20039949.
5. Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, et al. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(14):5215-20. doi: 10.1073/pnas.0501282102 PMID: 15784737; PubMed Central PMCID: PMC555037.
6. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO reports. 2004; 5(2):213-8. doi: 10.1038/sj.embor.7400074 PMID: 14749723; PubMed Central PMCID: PMC1298985.
7. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, Mizusawa H. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochemical and biophysical research communications. 2003; 312(4):1342-8. PMID: 14652021.
8. Waak J, Weber SS, Waldenmaier A, Gorner K, Alunni-Fabbroni M, Schell H, et al. Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2009; 23(8):2478-89. doi: 10.1096/fj.08-125153 PMID: 19276172.
9. Trudler D, Weinreb O, Mandel SA, Youdim MB, Frenkel D. DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline. Journal of neurochemistry. 2014; 129(3):434-47. doi: 10.1111/jnc.12633 PMID: 24355073.
10. Kim JH, Choi DJ, Jeong HK, Kim J, Kim DW, Choi SY, et al. DJ-1 facilitates the interaction between STAT1 and its phosphatase, SHP-1, in brain microglia and astrocytes: A novel anti-inflammatory function of DJ-1. Neurobiology of disease. 2013; 60:1-10. doi: 10.1016/j.nbd.2013.08.007 PMID: 23969237.
11. Hirsch EC, Vyas S, Hunot S. Neuroinflammation in Parkinson's disease. Parkinsonism & related disorders. 2012; 18 Suppl 1:S210-2. doi: 10.1016/S1353-8020(11)70065-7 PMID: 22166438.
12. Nguyen TA, Frank-Cannon T, Martinez TN, Ruhn KA, Marvin M, Casey B, et al. Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1(-/-) mice. Journal of neuroinflammation. 2013; 10:50.
13. Banks WA, Robinson SM. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain, behavior, and immunity. 2010; 24(1):102-9.
14. Huang Y, Cheung L, Rowe D, Halliday G. Genetic contributions to Parkinson's disease. Brain research Brain research reviews. 2004; 46(1):44-70. doi: 10.1016/j.brainresrev.2004.04.007 PMID: 15297154.
15. Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiology of disease. 2010; 37(3):510-8.
16. Good PF, Hsu A, Werner P, Perl DP, Olanow CW. Protein nitration in Parkinson's disease. Journal of neuropathology and experimental neurology. 1998; 57(4):338-42. PMID: 9600227.
17. Chao CC, Hu S, Ehrlich L, Peterson PK. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain, behavior, and immunity. 1995; 9(4):355-65. PMID: 8903852.
18. McLaughlin P, Zhou Y, Ma T, Liu J, Zhang W, Hong JS, et al. Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity. Glia. 2006; 53(6):567-82. doi: 10.1002/glia.20294 PMID: 16419087.
19. Arai H, Furuya T, Yasuda T, Miura M, Mizuno Y, Mochizuki H. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice. The Journal of biological chemistry. 2004; 279(49):51647-53. doi: 10.1074/jbc.M407328200 PMID: 15383538.
20. Domanskyi A, Geissler C, Vinnikov IA, Alter H, Schober A, Vogt MA, et al. Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2011; 25(9):2898-910. doi: 10.1096/fj.11-181958 PMID: 21593433.
21. Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW, et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature. 2013; 493(7433):532-6. doi: 10.1038/nature11713 PMID: 23235832; PubMed Central PMCID: PMC3554860.
22. Bifsha P, Yang J, Fisher RA, Drouin J. Rgs6 is required for adult maintenance of dopaminergic neurons in the ventral substantia nigra. PLoS genetics. 2014; 10(12):e1004863. doi: 10.1371/journal.pgen.1004863 PMID: 25501001; PubMed Central PMCID: PMC4263397.
23. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, et al. STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Nucleic acids research. 2009; 37(Database issue):D412-6. doi: 10.1093/nar/gkn760 PMID: 18940858; PubMed Central PMCID: PMC2686466.
24. Molina-Holgado F, Grencis R, Rothwell NJ. Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines. Glia. 2001; 33(2):97-106. PMID: 11180507.
25. Ock J, Han HS, Hong SH, Lee SY, Han YM, Kwon BM, et al. Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation. British journal of pharmacology. 2010; 159 (8):1646-62. PMID: 20397299; PubMed Central PMCID: PMC2925488.
26. Shi F, Yang L, Kouadir M, Yang Y, Wang J, Zhou X, et al. The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation. Journal of neuroinflammation. 2012; 9:73. doi: 10.1186/1742-2094-9-73 PMID: 22531291; PubMed Central PMCID: PMC3394218.
27. Xie Z, Morgan TE, Rozovsky I, Finch CE. Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity. Experimental neurology. 2003; 182(1):135-41. PMID: 12821383.
28. Henn A, Lund S, Hedtjarn M, Schrattenholz A, Porzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. Altex. 2009; 26(2):83-94. PMID: 19565166.
29. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. Journal of neuroimmunology. 1990; 27(2-3):229-37. PMID: 2110186.
30. Felice DL, Sun J, Liu RH. A modified methylene blue assay for accurate cell counting. Journal of Functional Foods. 2009; 1(1):109-18. doi: 10.1016/j.jff.2008.09.014
31. Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, et al. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Molecular psychiatry. 2006; 11(12):1116-25. doi: 10.1038/sj.mp.4001893 PMID: 16969367.
32. Galea E, Feinstein DL, Reis DJ. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proceedings of the National Academy of Sciences of the United States of America. 1992; 89(22):10945-9. PMID: 1279698; PubMed Central PMCID: PMC50459.
33. Long-Smith CM, Collins L, Toulouse A, Sullivan AM, Nolan YM. Interleukin-1beta contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro. Journal of neuroimmunology. 2010; 226(1-2):20-6. doi: 10.1016/j.jneuroim.2010.05.030 PMID: 20605229.
34. McNally RS, Davis BK, Clements CM, Accavitti-Loper MA, Mak TW, Ting JP. DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB. The Journal of biological chemistry. 2011; 286(6):4098-106. doi: 10.1074/jbc.M110.147371 PMID: 21097510; PubMed Central PMCID: PMC3039338.
35. Weinstein JR, Swarts S, Bishop C, Hanisch UK, Moller T. Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors. Glia. 2008; 56(1):16-26. doi: 10.1002/glia.20585 PMID: 17910052; PubMed Central PMCID: PMC2926344.
36. Roy A, Fung YK, Liu X, Pahan K. Up-regulation of microglial CD11b expression by nitric oxide. The Journal of biological chemistry. 2006; 281(21):14971-80. doi: 10.1074/jbc.M600236200 PMID: 16551637; PubMed Central PMCID: PMC1963414.
37. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008; 42(2):145-51. doi: 10.1016/j.cyto.2008.01.006 PMID: 18304834.
38. Lin YC, Uang HW, Lin RJ, Chen IJ, Lo YC. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells. The Journal of pharmacology and experimental therapeutics. 2007; 323(3):877-87. doi: 10.1124/jpet.107.125955 PMID: 17855475.
39. Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet neurology. 2009; 8(4):382-97. doi: 10.1016/S1474-4422(09)70062-6 PMID: 19296921.
40. Tanaka S, Ishii A, Ohtaki H, Shioda S, Yoshida T, Numazawa S. Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice. Journal of neuroinflammation. 2013; 10:143. doi: 10.1186/1742-2094-10-143 PMID: 24289537.
41. Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, et al. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2007; 27(12):3328-37. doi: 10.1523/JNEUROSCI.5321-06.2007 PMID: 17376993.
42. Guadagno J, Xu X, Karajgikar M, Brown A, Cregan SP. Microglia-derived TNFalpha induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma. Cell death & disease. 2013; 4:e538. doi: 10.1038/cddis.2013.59 PMID: 23492769; PubMed Central PMCID: PMC3613837.
43. Bal-Price A, Brown GC. Inflammatory neurodegeneration mediated by nitric oxide from activated gliainhibiting neuronal respiration, causing glutamate release and excitotoxicity. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2001; 21(17):6480-91. PMID: 11517237.
44. Delgado M. Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression. The Journal of biological chemistry. 2003; 278(30):27620-9. doi: 10.1074/jbc.M303199200 PMID: 12754213.
45. Platten M, Wick W, Wischhusen J, Weller M. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-gamma (IFN-gamma). British journal of pharmacology. 2001; 134(6):1279-84. doi: 10.1038/sj.bjp.0704373 PMID: 11704648; PubMed Central PMCID: PMC1573061.
46. Hayley S, Crocker SJ, Smith PD, Shree T, Jackson-Lewis V, Przedborski S, et al. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2004; 24(8):2045-53. doi: 10.1523/JNEUROSCI.4564-03.2004 PMID: 14985447.
47. Chakrabarty P, Ceballos-Diaz C, Lin WL, Beccard A, Jansen-West K, McFarland NR, et al. Interferon-gamma induces progressive nigrostriatal degeneration and basal ganglia calcification. Nature neuroscience. 2011; 14(6):694-6. doi: 10.1038/nn.2829 PMID: 21572432; PubMed Central PMCID: PMC3780582.
48. Rock RB, Hu S, Deshpande A, Munir S, May BJ, Baker CA, et al. Transcriptional response of human microglial cells to interferon-gamma. Genes and immunity. 2005; 6(8):712-9. doi: 10.1038/sj.gene.6364246 PMID: 16163375.
49. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. The Journal of experimental medicine. 1998; 187(12):2009-21. PMID: 9625760; PubMed Central PMCID: PMC2212354.
50. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. Journal of immunology. 2008; 181(6):3733-9. PMID: 18768823.
51. Appel SH, Beers DR, Henkel JS. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? Trends in immunology. 2010; 31(1):7-17. doi: 10.1016/j.it.2009.09.003 PMID: 19879804.
52. Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. The Journal of clinical investigation. 2009; 119(1):182-92. doi: 10.1172/JCI36470 PMID: 19104149; PubMed Central PMCID: PMC2613467.
53. Jung SH, Won KJ, Lee KP, Lee DH, Yu S, Lee DY, et al. DJ-1 protein regulates CD3+ T cell migration via overexpression of CXCR4 receptor. Atherosclerosis. 2014; 235(2):503-9. doi: 10.1016/j.atherosclerosis.2014.05.955 PMID: 24953490.